Ocular Therapeutix Corp - OCUL Net earnings per one share for the last twelve months

Public company logo of Ocular Pharma (OCUL)

Ocular Therapeutix enjoys high physician trust due to its advanced drug delivery methods. The annual net income per share TTM growth trend on the GURU.Markets service chart recorded a value of -1.40. The issuer plans to capture the ophthalmology segment using Axpaxli, although global political tensions and trade barriers significantly hinder the conduct of international clinical trials.

OCUL Ocular Therapeutix Corp: Earnings per share for the last twelve months in the range 02/11/2024 - 11/18/2026

Financial and market metric breakdowns for Ocular Pharma (OCUL)

Initial company analysis:Ocular Therapeutix, Inc. - OCUL
Manufactured product of Ocular Therapeutix Corp

Ocular Therapeutix develops innovative ophthalmologic implants, aiming to replace regular injections for macular degeneration. The rolling year earnings per share (EPS) trend quantifies the effectiveness of this commercialization, revealing market imbalances through EPS growth rates, which allows the GURU.Markets platform to determine the risk of buying the asset at its peak or the potential for business acceleration via the current EPS YoY TTM growth trend.

Competitor analysis for Ocular Therapeutix

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|Earnings per share for the last twelve months VRDN (Viridian Therapeutics, Inc.)|Net earnings per share (EPS TTM) LENZ (lenz-tx.com)|Net earnings per share (EPS TTM) oculis.com OCS|EyePoint Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Kodiak Sciences Inc. KOD|ALDX: Net earnings per share (EPS TTM)|KALA BIO, Inc. (KALA) - Net earnings per share (EPS TTM)|IRD (Opus Genetics Inc) - Net earnings per share (EPS TTM)|OKYO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ADVM (adverum.com)|OTLK - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLSD (Clearside Biomedical Inc)|Earnings per share for the trailing year NBY|Kiora Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Corp) - Net earnings per share for the last 12 months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters